106 related articles for article (PubMed ID: 6209508)
1. Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in the adult spontaneously hypertensive rat.
Uderman HD; Jackson EK; Puett D; Workman RJ
J Cardiovasc Pharmacol; 1984; 6(5):969-72. PubMed ID: 6209508
[TBL] [Abstract][Full Text] [Related]
2. Delay of the initiation of hypertension in spontaneously hypertensive rats by CV-4151, a specific thromboxane A2 synthetase inhibitor.
Shibouta Y; Terashita Z; Inada Y; Nishikawa K
Eur J Pharmacol; 1985 Feb; 109(2):135-44. PubMed ID: 3922775
[TBL] [Abstract][Full Text] [Related]
3. Effects of thromboxane synthase inhibition on vascular responsiveness in the in vivo rat mesentery.
Jackson EK
J Clin Invest; 1985 Dec; 76(6):2286-95. PubMed ID: 4077980
[TBL] [Abstract][Full Text] [Related]
4. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
5. 1-Benzylimidazole, a thromboxane synthetase inhibitor acutely lowers blood pressure mainly by alpha-adrenoceptor blockade in spontaneously hypertensive rats (SHR).
Lucas J; Chan PS; Mateja N; Cervoni P; Ronsberg MA; Lipchuck LM
Prostaglandins Leukot Med; 1983 Dec; 12(4):409-21. PubMed ID: 6142461
[TBL] [Abstract][Full Text] [Related]
6. Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat.
Quest DW; Wilson TW
Jpn J Pharmacol; 1998 Dec; 78(4):479-86. PubMed ID: 9920205
[TBL] [Abstract][Full Text] [Related]
7. A thromboxane A2 synthetase inhibitor retards hypertensive rat diabetic nephropathy.
Masumura H; Kunitada S; Irie K; Ashida S; Abe Y
Eur J Pharmacol; 1992 Jan; 210(2):163-72. PubMed ID: 1350991
[TBL] [Abstract][Full Text] [Related]
8. Role of thromboxane in control of arterial pressure and renal function in young spontaneously hypertensive rats.
Grone HJ; Grippo RS; Arendshorst WJ; Dunn MJ
Am J Physiol; 1986 Mar; 250(3 Pt 2):F488-96. PubMed ID: 3953827
[TBL] [Abstract][Full Text] [Related]
9. Renal effects of pinane-thromboxane A2 and indomethacin in saline volume-expanded spontaneously hypertensive rats.
Shibouta Y; Terashita ZI; Inada Y; Kato K; Nishikawa K
Eur J Pharmacol; 1982 Nov; 85(1):51-9. PubMed ID: 7151863
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane A2 and the development of hypertension in spontaneously hypertensive rats.
Stier CT; Itskovitz HD
Eur J Pharmacol; 1988 Jan; 146(1):129-35. PubMed ID: 3350054
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane synthesis and blood pressure in spontaneously hypertensive rats.
Purkerson ML; Martin KJ; Yates J; Kissane JM; Klahr S
Hypertension; 1986 Dec; 8(12):1113-20. PubMed ID: 3793195
[TBL] [Abstract][Full Text] [Related]
12. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats.
Stier CT; Benter IF; Levine S
Stroke; 1988 Sep; 19(9):1145-50. PubMed ID: 3413813
[TBL] [Abstract][Full Text] [Related]
14. Effects of selective inhibition of thromboxane synthesis on renal function in humans.
Zipser RD
Am J Physiol; 1985 Jun; 248(6 Pt 2):F753-6. PubMed ID: 3839111
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction augments myogenic arteriolar constriction in hypertension.
Huang A; Sun D; Koller A
Hypertension; 1993 Dec; 22(6):913-21. PubMed ID: 8244524
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane A2 does not play a role in the development or maintenance of hypertension in spontaneously hypertensive rats.
Stegmeier K; Sponer G; Pill J
Prog Clin Biol Res; 1987; 242():253-7. PubMed ID: 2959964
[No Abstract] [Full Text] [Related]
17. Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension.
Mistry M; Nasjletti A
Hypertension; 1988 Jun; 11(6 Pt 2):758-62. PubMed ID: 3164706
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.
Patrignani P; Filabozzi P; Catella F; Pugliese F; Patrono C
J Pharmacol Exp Ther; 1984 Feb; 228(2):472-7. PubMed ID: 6537977
[TBL] [Abstract][Full Text] [Related]
19. Role of the prostaglandin-thromboxane system in the development and maintenance of spontaneous hypertension in the rat.
Yasujima M; Abe K; Tanno M; Kohzuki M; Sato M; Omata K; Takeuchi K; Hagino T; Yoshinaga K
Agents Actions Suppl; 1987; 22():133-8. PubMed ID: 3124554
[TBL] [Abstract][Full Text] [Related]
20. Effects of thromboxane synthetase inhibitor (OKY-046) on placental blood flow, placental weight and fetal weight in normotensive and spontaneously hypertensive rats.
Furuhashi N; Tsujiei M; Kimura H; Nagae H; Yajima A
Gynecol Obstet Invest; 1993; 35(1):23-6. PubMed ID: 8449429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
